Escherichia coli K5 heparosan fermentation and improvement by genetic engineering

Bioengineered Bugs

Volumn 2, Issue 1, 2011, Pages 63-67

  Wang, Zhenyu ^a   Dordick, Jonathan S ^a,b   Linhardt, Robert J ^a,b,c  

^a Research Rensselaer Polytechnic Institute   (United States)

^b Rensselaer Polytechnic Institute   (United States)

^c RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

Fermentation; Heparin; Heparosan; K5 capsule polysaccharide

Indexed keywords

GLYCOSAMINOGLYCAN POLYSULFATE; HEPARIN;

ARTICLE; ESCHERICHIA COLI; FERMENTATION; GENETIC ENGINEERING; NONHUMAN;

ESCHERICHIA COLI;

EID: 78751622326     PISSN: 19491018     EISSN: 19491026     Source Type: Journal    
DOI: 10.4161/bbug.2.1.14201     Document Type: Article

References (39)

1. Linhardt RJ, Claude S. Hudson Award address in carbohydrate chemistry. Heparin: Structure and activity. J Med Chem 2003; 46:2551-64.
2. Linhardt RJ, Toida T. Role of glycosaminoglycans in cellular communication. Acc Chem Res 2004; 37:431-8.
3. Liu H, Zhang Z, Linhardt RJ. Lessons learned from the contamination of heparin. Nat Prod Rep 2009; 26:313-21.
4. Kishimoto TK, Viswanathan K, Ganguly T, Elankumaran S, Smith S, Pelzer K, et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. New Engl J Med 2008; 358:2457-67.
5. Guerrini M, Beccati D, Shriver Z, Naggi A, Viswanathan K, Bisio A, et al. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol 2008; 26:669-75.
6. Lindahl U, Li JP, Kusche-Gullberg M, Salmivirta M, Alaranta S, Veromaa T, et al. Generation of "Neoheparin" from E. coli K5 capsular polysaccharide. J Med Chem 2005; 48:349-52.
7. Kuberan B, Beeler DL, Lech M, Wu ZL, Rosenberg RD. Chemoenzymatic synthesis of classical and non-classical anticoagulant heparan sulfate polysaccharides. J Biol Chem 2003; 278:52613-21.
8. Chen J, Avci FY, Munoz EM, McDowell LM, Chen M, Pedersen LC, et al. Enzymatic redesigning of biologically active heparan sulfate. J Biol Chem 2005; 280:42817-25.
9. Zhang ZQ, McCallum SA, Xie J, Nieto L, Corzana F, Jimenez-Barbero J, et al. Solution structures of chemoenzymatically synthesized heparin and its precursors. J Am Chem Soc 2008; 130:12998-3007.
10. Wang Z, Ly M, Zhang F, Zhong W, Suen A, Hickey AM, et al. E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor. Biotechnol Bioeng 2010; 107:968-77.
11. Vann WF, Schmidt MA, Jann B, Jann K. The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin. Eur J Biochem 1981; 116:359-64.
12. Manzoni M, Bergomi S, Cavazzoni V. Extracellular K5 Polysaccharide of Escherichia Coli- Production and Characterization. J Bioact Compat Polym 1993; 8:251-7.
13. DeAngelis PL, White CL. Identification and molecular cloning of a heparosan synthase from Pasteurella multocida type D. J Biol Chem 2002; 277:7209-13.
14. Deangelis PL. Heparosan-based biomaterials and coatings and methods of production and use. PCT Int Appl 2009; 2009 014559.
15. Manzoni M, Bergomi S, Cavazzoni V. Production of K5 polysaccharides of different molecular weight by Escherichia coli. J Bioact Compat Polym 1996; 11:301-11.
16. Finke A, Bronner D, Nikolaev AV, Jann B, Jann K. Biosynthesis of the Escherichia coli K5 polysaccharide, a representative of group II capsular polysaccharides: Polymerization in vitro and characterization of the product. J Bacteriol 1991; 173:4088-94.
17. Sugiura N, Baba Y, Kawaguchi Y, Iwatani T, Suzuki K, Kusakabe T, et al. Glucuronyltransferase activity of KfiC from Escherichia coli strain K5 requires association of KfiA: KfiC and KfiA are essential enzymes for production of K5 polysaccharide, N-acetylheparosan. J Biol Chem 2010; 285:1597-606.
18. Hodson N, Griffiths G, Cook N, Pourhossein M, Gottfridson E, Lind T, et al. Identification that KfiA, a protein essential for the biosynthesis of the Escherichia coli K5 capsular polysaccharide, is an alpha-UDP-GlcNAc glycosyltransferase. The formation of a membrane-associated K5 biosynthetic complex requires KfiA, KfiB and KfiC. J Biol Chem 2000; 275:27311-5.
19. Whitfield C, Roberts IS. Structure, assembly and regulation of expression of capsules in Escherichia coli. Mol Microbiol 1999; 31:1307-19.
20. Arrecubieta C, Hammarton TC, Barrett B, Chareonsudjai S, Hodson N, Rainey D, et al. The transport of group 2 capsular polysaccharides across the periplasmic space in Escherichia coli. Roles for the KpsE and KpsD proteins. J Biol Chem 2001;
21. McNulty C, Thompson J, Barrett B, Lord L, Andersen C, Roberts IS. The cell surface expression of group 2 capsular polysaccharides in Escherichia coli: The role of KpsD, RhsA and a multi-protein complex at the pole of the cell. Mol Microbiol 2006; 59:907-22.
22. Silver RP, Prior K, Nsahlai C, Wright LF. ABC transporters and the export of capsular polysaccharides from gram-negative bacteria. Res Microbiol 2001; 152:357-64.
23. Jann B, Jann K. Structure and biosynthesis of the capsular antigens of Escherichia coli. Curr Top Microbiol Immunol 1990; 150:19-42.
24. Lee SY. High cell-density culture of Escherichia coli. Trends Biotechnol 1996; 14:98-105.
25. Johnston WA, Stewart M, Lee P, Cooney MJ. Tracking the acetate threshold using DO-transient control during medium and high cell density cultivation of recombinant Escherichia coli in complex media. Biotechnol Bioeng 2003; 84:314-23.
26. Lee SY, Chang HN. High cell density cultivation of Escherichia coli W using sucrose as a carbon source. Biotechnol Lett 1993; 15:971-4.
27. Roman E, Roberts I, Lidholt K, Kusche-Gullberg M. Overexpression of UDP-glucose dehydrogenase in Escherichia coli results in decreased biosynthesis of K5 polysaccharide. Biochem J 2003; 374:767-72.
28. Schiller JG, Lamy F, Frazier R, Feingold DS. UDP-glucose dehydrogenase from Escherichia coli. Purification and subunit structure. Biochim Biophys Acta 1976; 453:418-25.
29. Chong BF, Blank LM, McLaughlin R, Nielsen LK. Microbial hyaluronic acid production. Appl Microbiol Biotechnol 2005; 66:341-51.
30. Lidholt K, Riesenfeld J, Jacobsson KG, Feingold DS, Lindahl U. Biosynthesis of heparin. Modulation of polysaccharide chain length in a cell-free system. Biochem J 1988; 254:571-8.
31. Hanfling P, Shashkov AS, Jann B, Jann K. Analysis of the enzymatic cleavage (beta elimination) of the capsular K5 polysaccharide of Escherichia coli by the KS-specific coliphage: A reexamination. J Bacteriol 1996; 178:4747-50.
32. Manzoni M, Bergomi S, Rollini M. Influence of the culture conditions on extracellular lyase activity related to K5 polysaccharide. Biotechnol Lett 2000; 22:81-5.
33. Whitfield C. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev Biochem 2006; 75:39-68.
34. Taylor CM, Goldrick M, Lord L, Roberts IS. Mutations in the waaR gene of Escherichia coli which disrupt lipopolysaccharide outer core biosynthesis affect cell surface retention of group 2 capsular polysaccharides. J Bacteriol 2006; 188:1165-8.
35. Ly M, Wang Z, Laremore TN, Zhang F, Zhong W, Pu D, et al. Analysis of E. coli K5 capsular polysaccharide heparosan. Anal Bioanal Chem 2010; Epub ahead of print.
36. Rota C, Liverani L, Spelta F, Mascellani G, Tomasi A, Iannone A, et al. Free radical generation during chemical depolymerization of heparin. Anal Biochem 2005; 344:193-203.
37. Myette JR, Shriver Z, Kiziltepe T, McLean MW, Venkataraman G, Sasisekharan R. Molecular cloning of the heparin/heparan sulfate delta 4,5-unsaturated glycuronidase from Flavobacterium heparinum, its recombinant expression in Escherichia coli, and biochemical determination of its unique substrate specificity. Biochemistry 2002; 41:7424-34.
38. Lee CC, Wong DW, Robertson GH. An E. coli expression system for the extracellular secretion of barley alpha-amylase. J Protein Chem 2001; 20:233-7.
39. Khushoo A, Pal Y, Singh BN, Mukherjee KJ. Extracellular expression and single step purification of recombinant Escherichia coli L-asparaginase II. Protein Expr Purif 2004; 38:29-36.